MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer

被引:23
作者
Gao, Heli
Cong, Xuejing
Zhou, Jianfeng
Guan, Mei [1 ]
机构
[1] Chinese Acad Med Sci, Dept Oncol, Peking Union Med Coll Hosp, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-222; MIA3; Colorectal cancer; Migration; Invasion; EXPRESSION PROFILES; MIR-222; COLON; 5-FLUOROURACIL; PROLIFERATION; RESISTANCE; CARCINOMA; MANNER; CELLS; TANGO;
D O I
10.1186/s12935-017-0447-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: miR-222 has been reported to be overexpressed in colorectal cancer and it influences cancer cell proliferation, drug resistance and metastasis. However, the underlying molecular mechanism of miR-222 in colorectal cancer cell invasion and migration has not been thoroughly elucidated to date. Methods: The cell cycle distribution and apoptosis were assessed by flow cytometry. Cell migration and invasion were analyzed by Transwell assays. The possible target gene of miR-222 was searched and identified by bioinformatics, dual luciferase reporter assay and western blot analysis. The siRNA method was used to confirm the function of the target gene. Results: Overexpression of miR-222 effectively promotes migration and invasion of colorectal cancer (CRC) cells in vitro. Bioinformatics and the dual luciferase reporter assay revealed that miR-222 specifically targeted the 3'-UTR of melanoma inhibitory activity member 3 (MIA3), down-regulating its expression at the protein level. Inhibition of MIA3 by siRNA enhanced the migration and invasion of CRC cell lines. Conclusions: Our study showed that miR-222 enhances the migration and invasion in CRC cells, primarily by down-regulation of MIA3.
引用
收藏
页数:10
相关论文
共 26 条
  • [1] miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
    Acunzo, M.
    Visone, R.
    Romano, G.
    Veronese, A.
    Lovat, F.
    Palmieri, D.
    Bottoni, A.
    Garofalo, M.
    Gasparini, P.
    Condorelli, G.
    Chiariello, M.
    Croce, C. M.
    [J]. ONCOGENE, 2012, 31 (05) : 634 - 642
  • [2] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [3] Arndt S, 2007, ONCOL REP, V18, P885
  • [4] TANGO is a tumor suppressor of malignant melanoma
    Arndt, Stephanie
    Bosserhoff, Anja K.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2812 - 2820
  • [5] Functional genomics reveals genes involved in protein secretion and Golgi organization
    Bard, F
    Casano, L
    Mallabiabarrena, A
    Wallace, E
    Saito, K
    Kitayama, H
    Guizzunti, G
    Hu, Y
    Wendler, F
    DasGupta, R
    Perrimon, N
    Malhotra, V
    [J]. NATURE, 2006, 439 (7076) : 604 - 607
  • [6] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [7] Dassow H, 2013, CURR PHARM DESIGN, V19, P1242
  • [8] MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
    Feng, Y.
    Zhu, J.
    Ou, C.
    Deng, Z.
    Chen, M.
    Huang, W.
    Li, L.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2300 - 2309
  • [9] miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
    Garofalo, M.
    Quintavalle, C.
    Romano, G.
    Croce, C. M.
    Condorelli, G.
    [J]. CURRENT MOLECULAR MEDICINE, 2012, 12 (01) : 27 - 33
  • [10] In Vivo Imaging of Functional Targeting of miR-221 in Papillary Thyroid Carcinoma
    Kim, Hyun Joo
    Kim, Young Ha
    Lee, Dong Soo
    Chung, June-Key
    Kim, Soonhag
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (10) : 1686 - 1693